Profile image
Story Views

Last Hour:
Last 24 Hours:

Uveitis Market, Therapeutics Landscape and Pipeline Review H2 2016

Friday, November 11, 2016 2:56
% of readers think this story is Fact. Add your two cents.

Latest Uveitis Pipeline Review, H2 2016, provides in depth analysis on Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) targeted pipeline therapeutics.

Uveitis therapeutics industry report provides comprehensive information on the therapeutics under development for Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Uveitis and features dormant and discontinued projects.

Browse more detail information about Uveitis market report at:


Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or inflammatory disorder and history of eye injury. Treatment includes steroid eye drops, anti-inflammatory and antibiotic or antiviral medication.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key players in Uveitis – Pipeline Review, H2 2016:

  • 2-BBB Medicines BV
  • AbbVie Inc
  • Aciont Inc.
  • Aldeyra Therapeutics Inc
  • Apitope International NV
  • Astellas Pharma Inc.
  • Bionomics Limited
  • Bristol-Myers Squibb Company
  • Can-Fite BioPharma Ltd.
  • Clearside BioMedical, Inc.
  • Endocyte, Inc.
  • Enzo Biochem, Inc.
  • EyeGate Pharmaceuticals, Inc.

Get a PDF Sample of Uveitis Market Research Report at:

Drug Profiles of Included in Uveitis Therapeutics Development Market Report

  • 2-B3201
  • ANV-103
  • ATXUV-1
  • ATXUV-2
  • B27-PD
  • BNC-164
  • celecoxib

And other drug profiles

Have any query? ask our expert @

Key Topics Covered:
2.Uveitis Overview
3.Uveitis Therapeutics Development
4.Pipeline Products for Uveitis – Overview
5.Pipeline Products for Uveitis – Comparative Analysis
6.Uveitis – Therapeutics under Development by Companies
7.Uveitis – Therapeutics under Investigation by Universities/Institutes
8.Uveitis Products Glance
9.Late Stage Products
10.Clinical Stage Products
11.Early Stage Products
12.Uveitis – Products under Development by Companies
13.Uveitis – Products under Investigation by Universities/Institutes
14.Uveitis – Companies Involved in Therapeutics Development
15.Uveitis Drug Profiles
16.Uveitis Dormant Projects
17.Uveitis Discontinued Products
18.Uveitis Featured News & Press Releases
And Continue…


Get Discount on Uveitis Market Research Report at:

This research study help to:
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Uveitis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Uveitis pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


About Absolute Report:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.


Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email –


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global

Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.